Clementia Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Clementia Pharmaceuticals's estimated annual revenue is currently $8M per year.
- Clementia Pharmaceuticals's estimated revenue per employee is $118,235
- Clementia Pharmaceuticals's total funding is $102.5M.
- Clementia Pharmaceuticals has 68 Employees.
- Clementia Pharmaceuticals grew their employee count by 31% last year.
- Clementia Pharmaceuticals currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is Clementia Pharmaceuticals?
Clementia is a privately held clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for people living with rare diseases by exploiting the science of novel retinoic acid receptor gamma agonists to address bone diseases, including Fibrodysplasia Ossificans Progressiva (FOP).keywords:N/A
Number of Employees
Employee Growth %
Clementia Pharmaceuticals News
Investors are keeping a close eye on shares of Clementia Pharmaceuticals Inc. (CMTA). The stock has a current six month price index of ...
Ipsen (Euronext: IPN; ADR: IPSEY) and Clementia Pharmaceuticals (NASDAQ: CMTA) today announced the closing of Ipsen's acquisition of ...
Fibrodysplasia Ossificans Progressiva Drug Market Report by Material, Application, and Geography – Global Forecast to 2024 is a professional and in-depth ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|